Skip to main content
. 2015 Aug 20;10:99. doi: 10.1186/s13023-015-0321-y

Table 1.

Patients without evidence of CNS abnormalities

Patient Sex Age at last report years MAT1A allele 1/allele 2 MAT activity % of WT Cause ascer- tain Met Age < 5 m Met range Age ≥ 5 m Met mean ± SD MRI (age) Citation
G1 F 40.4 c.966T>G (p.Ile322Met) 7.8* NBS 1270 373 ± 133 Normal (22) [17, 25, 46, 58]
c.966T>G (p.Ile322Met) 21/21
G2 M 38 c.914T>C (p.Leu305Pro) 10.2* NBS 364–583 394 ± 118 --- [17, 25]
c.966T>G (p.Ile322Met) 26/21
G3 F 2 c.164C>A (p.Arg55Asp) 10.91* NBS 389–1020 315 --- [17, 25]
c.1070C>T (p.Pro357Leu) 26/31
G4 F 31.4 c.1068G>A (p.Arg356Gln) 17.5* NBS 42–408 146 ± 38 --- [17, 26]
c.1132G>A (p.Gly378Ser) 11/0.2 402
2 M 60.1 c.539insTG (p.Thr185X) 28* Breath odor --- 805 ± 106 Normal (31) [19, 20, 78]
c.539insTG (p.Thr185X)
3 F 21.5 c.539insTG (p.Thr185X) NA NBS 1870–2542 777 ± 169 Normal (6) [26, 58]
c.539insTG (p.Thr185X) 1870
10a M 25 c.595C>T (p.Arg199Cys) 11/11 NBS 496–670 520 ± 124 --- [26, 58]
c.595C>T (p.Arg199Cys) 670
11a F 28.5 c.595C>T (p.Arg199Cys) 11/11 NBS 591–654 475 ± 118 --- [26, 58]
c.595C>T (p.Arg199Cys) 591
14 F 6.4 c.966T>G (p.Ile322Met) 11/11 NBS 440–467 225 ± 57 --- [27, 58]
c.1031A>C (p.Glu344Ala)
15b F 2.2 c.1132G>A (p.Gly378Ser) 0.2/75 NBS 383–1089 519 --- [80]
c.1161G>A (p.Trp387X)
16b F 4.7 c.1132G>A (p.Gly378Ser) 0.2/75 Family --- 782 ± 400 --- [80]
c.1161G>A (p.Trp387X)
17 F 21.4 c.791C>T (p.Arg264Cys) 0.3/31 NBS 648 322 --- [42]
c.1070C>T (p.Pro357Leu)
18 M 21.2 c.1070C>T (p.Pro357Leu) 31/31 NBS 505 325 ± 244 --- [42]
c.1070C>T (p.Pro357Leu)
19 F 16.5 c.1067G>C (p.Arg356Pro) 11/31 NBS 622 175 --- [34, 42]
c.1070C>T (p.Pro357Leu)
21 F 7.1 c.836G>T (p.Gly279Val) NA/2 NBS 596 436 ± 1 --- [34]
c.964A>G (p.Ile322Val)
23 F 3.9 c.539insTG (p.Thr185X) NA NBS 216–1457 665 ± 160 --- [38]
c.822G>C (p.Trp274Ser)
24c M 1.2 c.689T>G (p.Val230Gly) NA NBS 518–525 769 ± 112 ---
c.689T>G (p.Val230Gly)
25c F 4.9 c.689T>G (p.Val230Gly) NA Family 838 ± 18 ---
c.689T>G (p.Val230Gly)
26 F 2.9 c.527T>A (p.Leu176Gln) NA NBS 57 57–200 76 ± 24 ---
c.527T>A (p.Leu176Gln)
28 F 20 c.65C>T (p.Ser22Leu) 46/46 NBS --- 975 ± 177 normal (20) [34, 37, 44]
c.65C>T (p.Ser22Leu)
33 U 2 c.856G>A (p.Asp286Asn) NA NBS 106–1570
del at least exons 6-8
40 F 0.4 c.1141G>A (p.Gly381Arg) 25/25 NBS 1207–2121 1673 --- [34]
c.1141G>A (p.Gly381Arg)
44 M 0.2 c.529C>T (p.Arg177Trp) NA NBS 97 97–641 --- ---
c.529C>T (p.Arg177Trp)
48 M 5.4 c.446T>A (p.Met64Lys) NA NBS 134 134–1567 --- Normal (yearly, final at 5) DQ 88 [39]
c.589delC (p.Pro197Leufs*26)
49 F 0.3 c.110T>C (p.Ile37Thr) NA NBS 407 403–408 --- --- [31]
c.271G>A (p.Gly91Ser)
52 M 0.54 c.823G>C (p.Gly275Arg) NA NBS 949–1074 --- normal (0.5)
c.823G>C (p.Gly275Arg)
53 F 2.3 c.862A>G (p.Thr288Ala) NA NBS 121–484 495 ± 275 [30]
c.862A>G (p.Thr288Ala)
54 F 2.0 c.1064T>G (p.Leu355Arg) NA NBS 185 185–410 --- --- [30]
c.1064T>G (p.Leu355Arg)
57 U 3.5 c.169+1G>A NA NBS 860 860–1130 918 ± 84 ---
c.169+1G>A
58d M 12.3 not sequenced 22.7* NBS 268–1005 369 ± 237 --- [15]
268
59d M 13.7 not sequenced 23.1* Family --- 350 ± 50 --- [15]
64 M 4.5 m c.596G>A (p.Arg199His) NA NBS 118–208 --- ---
c.596G>A (p.Arg199His)

Patients are assigned the same identifiers as were used when they were first described in the following papers: Patients G1, G2, G3, G4 [17]; Patients 3, 10, 11 [58]; Patients 17, 18, 19; numbers 1, 2 and 5 [42]; Patient 28: patient 1 [44]; Patients 53, 54: patients 14 and 18 [30]

*Activity based on assay of hepatic extract; others based on activity of mutant recombinant forms expressed in E coli [34]

aSibs are designated by the same superscript

Cont. indicates that methionine restriction or AdoMet supplementation was continuing at last report

NBS: Newborn screening

NA: not available

Met: methionine concentration in umol/L